# A Randomized Phase II Trial of Neoadjuvant Chemotherapy Compared With Chemoradiotherapy in Gastric Adenocarcinoma

> **NCT02301481** · PHASE2 · COMPLETED · sponsor: **Chinese Academy of Medical Sciences** · enrollment: 71 (actual)

## Conditions studied

- Stomach Neoplasms
- Neoadjuvant Therapy
- Chemoradiotherapy
- Chemotherapy

## Interventions

- **RADIATION:** SIB-IMRT
- **DRUG:** S-1
- **PROCEDURE:** Surgery
- **DRUG:** SOX

## Key facts

- **NCT ID:** NCT02301481
- **Lead sponsor:** Chinese Academy of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-01
- **Primary completion:** 2016-12
- **Final completion:** 2017-12
- **Target enrollment:** 71 (ACTUAL)
- **Last updated:** 2019-10-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02301481

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02301481, "A Randomized Phase II Trial of Neoadjuvant Chemotherapy Compared With Chemoradiotherapy in Gastric Adenocarcinoma". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02301481. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*